NCT05916560View on ClinicalTrials.gov

A Study of LY3437943 in Participants With Impaired and Normal Liver Function

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

July 13, 2023

Primary Completion Date

March 2, 2025

Study Completion Date

March 2, 2025

Conditions
HealthyHepatic Insufficiency
Interventions
DRUG

LY3437943

Administered SC.

Trial Locations (5)

32720

Accel Research Sites- Clinical Research Unit, DeLand

78215

American Research Corporation at Texas Liver Institute, San Antonio

78229

Pinnacle Clinical Research, San Antonio

85225

Arizona Clinical Trials - Chandler, Chandler

33147-4040

Advanced Pharma Clinical Research, Miami

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY